Business · 17/07/2002
FDA to Host Public Workshop on Reducing Pathogens in Cellular Blood Products
The US Food and Drug Administration (FDA) will host a public workshop to discuss methods for reducing pathogens in cellular blood products used in transfusions, a crucial step in ensuring the safety of patients receiving these life-saving treatments.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →